We're building next generation computational technology that unlocks insights from each sample for doctors to optimize patient outcomes.
Paige is a software company helping pathologists and clinicians make faster, more informed diagnostic and treatment decisions by mining decades of data from the world’s experts in cancer care. We are leading a digital transformation in pathology by leveraging advanced Artificial Intelligence (AI) technology to create value for the oncology clinical team. Paige is the first company to develop clinical grade AI tools for the pathologist, which resulted in our receiving FDA breakthrough designation for our first product.
Build next generation computational technology that unlocks insights from each sample for doctors to optimize patient outcomes.
Create a world where patients get deep, comprehensive insights into their biology, so diagnoses translate into effective, personalized treatments.
With a potential 60 percent increase in the number of cancer cases globally in the next two decades and a decrease in the number of pathologists relative to this diagnostic demand, the need to expedite advancements in pathology is pressing. This issue is further exacerbated by the fact that pathology — despite being the foundation of diagnosis — has yet to become digital.
Led by a team of experts in pathology, machine learning, healthcare, and business, Paige strives to make it possible to not only provide additional information from digital slides to help pathologists perform their diagnostic work efficiently and accurately, but also to go beyond this traditional work to extract new diagnostic information from pathology slides and patient samples that have the potential to support informed treatment pathways for patients. Paige technology is also helping life sciences companies evaluate and design personalized treatments for patients.